BioNTech says vaccine approval possible in mid-Dec under ideal conditions

US and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of positive trial results.

from bdnews24.com - Home https://ift.tt/2UC3b3M

No comments